RecruitingNCT03334292
Natural History of Wilson Disease
Natural History of Wilson Disease: Registry for Patients With Wilson Disease
Sponsor
Yale University
Enrollment
300 participants
Start Date
Dec 18, 2017
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of the registry/repository is to provide a mechanism to store data and specimens to support the conduct of future research about Wilson disease (WD). The overall aim is to determine the optimal testing for diagnosis and parameters for monitoring treatment of WD that will aid product utilization and development.
Eligibility
Inclusion Criteria2
- Known diagnosis of WD
- Able and willing to provide informed consent for adults (Parental/guardian permission (informed consent) and if appropriate, child assent for participants <18 (or per local Institutional Review Board (IRB) regulation)
Exclusion Criteria2
- Diagnosis of WD has been excluded
- Unwilling to provide informed consent or assent
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(6)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03334292
Related Trials
Prescreening Study to Identify Potential Wilson Disease Participants for Gene-Editing Clinical Trial
NCT072266227 locations
Off Treatment Urinary Copper Excretion in Wilson Disease, Pilot Study
NCT073012161 location
Wilson's Disease Treated With D-Penicillamine: Characterization of Skin Damage Secondary to Treatment by Measuring Skin Elasticity
NCT069450812 locations
A Clinical Study to Evaluate the Safety and Efficacy of LY-M003 Injection in Patients With Wilson Disease
NCT066503191 location
Circadian Variation of Urinary Copper Excretion in Wilson Disease Patients
NCT064303591 location